Primary care app engagement was limited, with differences by substance type
Real-world use of digital therapeutics for substance use disorders in primary care: Observational study of the engagement cascade by substance type.
AI Summary
This observational study examined engagement with FDA-authorized digital treatments for substance use disorder among 83 primary care patients prescribed reSET or reSET-O. The researchers compared engagement across patients identified as having unhealthy alcohol, cannabis, or other drug use. The primary outcome was progression through four app-use milestones, from activation to vendor-defined treatment completion.
Overall, 50.6% activated the app, 45.8% completed the user guide, 38.6% completed at least one module, and 13.3% met the treatment-completion criterion. Engagement was concentrated early: among app activators, half of module users stopped by week 4. Unhealthy alcohol use was associated with higher odds of several engagement milestones, while cannabis and other drug use were not associated with them. These observational findings cannot establish why engagement differed or whether the digital treatments improved health outcomes; this is an abstract-based summary, and the authors call for further research to validate the results.
๐ก Key Findings
๐
Original Abstract
Related Research
Similar Studies
More Addiction research papers you might find interesting.
Review finds strongest evidence in select seizure and MS symptoms
Racism-related distress linked to cannabis problems in Asian American adults
Review maps digital CBT for substance use, but does not establish efficacy
Explore More Research
Stay informed about the latest cannabis science.